Franklin Resources’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $326M | Buy |
|
|||||
|
2025
Q2 | $196M | Buy |
|
|||||
|
2025
Q1 | $124M | Buy |
|
|||||
|
2024
Q4 | $97.5M | Buy |
|
|||||
|
2024
Q3 | $109M | Buy |
|
|||||
|
2024
Q2 | $70.3M | Buy |
|
|||||
|
2024
Q1 | $35.5M | Buy |
|
|||||
|
2023
Q4 | $28.9M | Buy |
|
|||||
|
2023
Q3 | $26.6M | Sell |
|
|||||
|
2023
Q2 | $28.6M | Sell |
|
|||||
|
2023
Q1 | $32.2M | Sell |
|
|||||
|
2022
Q4 | $38.2M | Buy |
|
|||||
|
2022
Q3 | $31.9M | Buy |
|
|||||
|
2022
Q2 | $22.8M | Sell |
|
|||||
|
2022
Q1 | $31.3M | Sell |
|
|||||
|
2021
Q4 | $35.7M | Buy |
|
|||||
|
2021
Q3 | $28.3M | Buy |
|
|||||
|
2021
Q2 | $611K | Buy |
|
|||||
|
2021
Q1 | $436K | Sell |
|
|||||
|
2020
Q4 | $466K | Sell |
|
|||||
|
2020
Q3 | $18.2M | Buy |
|
|||||
|
2020
Q2 | $19.6M | Sell |
|
|||||
|
2020
Q1 | $13.5M | Sell |
|
|||||
|
2019
Q4 | $14.6M | Sell |
|
|||||
|
2019
Q3 | $16M | Sell |
|
|||||
|
2019
Q2 | $14.5M | Sell |
|
|||||
|
2019
Q1 | $18.6M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $7.77M | Sell |
|
|||||
|
2018
Q1 | $14.9M | Buy |
|
|||||
|
2017
Q4 | $6.4M | Buy |
|
|||||
|
2017
Q3 | $2.32M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $26.1M | Sell |
|
|||||
|
2016
Q4 | $19.5M | Sell |
|
|||||
|
2016
Q3 | $48.4M | Buy |
|
|||||
|
2016
Q2 | $32.9M | Sell |
|
|||||
|
2016
Q1 | $59.2M | Sell |
|
|||||
|
2015
Q4 | $91.1M | Buy |
|
|||||
|
2015
Q3 | $75.4M | Sell |
|
|||||
|
2015
Q2 | $121M | Sell |
|
|||||
|
2015
Q1 | $118M | Sell |
|
|||||
|
2014
Q4 | $207M | Sell |
|
|||||
|
2014
Q3 | $177M | Sell |
|
|||||
|
2014
Q2 | $160M | Sell |
|
|||||
|
2014
Q1 | $175M | Buy |
|
|||||
|
2013
Q4 | $138M | Buy |
|
|||||
|
2013
Q3 | $131M | Buy |
|
|||||
|
2013
Q2 | $8.81M | Buy |
|